Inhaler Patents 'Must Be' In Orange Book, Teva Tells Fed. Circ.
By Bryan Koenig · July 31, 2024, 7:29 PM EDT
Teva Pharmaceuticals USA Inc. urged the Federal Circuit to upend a lower court decision ejecting inhaler device patents from an important government database, arguing that the delisting, won by Amneal Pharmaceuticals...
To view the full article, register now.